Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin, Baek Gyu Jun, Sang-Wook Yi
Clin Mol Hepatol. 2022;28(4):773-789.   Published online 2022 Aug 8     DOI: https://doi.org/10.3350/cmh.2021.0383
Citations to this article as recorded by Crossref logo
Towards elimination of chronic viral hepatitis in French Polynesia: results from a national population-based survey
Iotefa Teiti, Maite Aubry, Philippe Glaziou, Vincent Mendiboure, Anita Teissier, Tuterarii Paoaafaite, Aurélie Simon, Kiyojiken Chung, Lisa Dian, Sophie Olivier, Pascal Pineau, Arnaud Fontanet, Bertrand Condat, Yoann Madec, Stéphane Lastère, Van-Mai Cao-L
The Lancet Regional Health - Western Pacific.2024; 45: 101035.     CrossRef
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Pinggui Chen, Yaoxuan Li, Yunyan Dai, Zhiming Wang, Yunpeng Zhou, Yi Wang, Gaopeng Li
Journal of Hepatocellular Carcinoma.2024; Volume 11: 581.     CrossRef
Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
Man-Yu Li, Ting-Ting Li, Ke-Jian Li, Cheng Zhou
World Journal of Clinical Cases.2023; 11(5): 1009.     CrossRef
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S43.     CrossRef
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clinical and Molecular Hepatology.2023; 29(Suppl): S228.     CrossRef
A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
Hao-dan Mao, Shu-qin Zheng, Su-hua Yang, Ze-yu Huang, Yuan Xue, Min Zhou
PeerJ.2023; 11: e15014.     CrossRef
Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation
Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani
Expert Review of Anticancer Therapy.2023; 23(5): 503.     CrossRef
Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Mona Mohamed Ibrahim Abdalla
World Journal of Gastroenterology.2023; 29(27): 4271.     CrossRef
On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
Zeyuan Yang, Ramsey C. Cheung, Amit S. Chitnis, Wei Zhang, Robert G. Gish, Robert J. Wong
JHEP Reports.2023; 5(10): 100852.     CrossRef
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study
Fahim Ebrahimi, Hannes Hagström, Jiangwei Sun, David Bergman, Ying Shang, Wen Yang, Bjorn Roelstraete, Jonas F. Ludvigsson
Journal of Hepatology.2023; 79(6): 1374.     CrossRef
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study
Hashem B. El-Serag, Ghida Akhdar, Aaron P. Thrift, Michelle Luster, Saira Khaderi, Abeer Alsarraj, Hao Duong, Fasiha Kanwal
Hepatology Communications.2023;[Epub]     CrossRef
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy—Author's reply
Eiichi Ogawa
Alimentary Pharmacology & Therapeutics.2023; 58(8): 845.     CrossRef
Effects of visceral obesity on cytokine and hormonal regulation in patients with gastroesophageal reflux disease
Yu.M. Stepanov, L.M. Mosiychuk, O.M. Tatarchuk, O.M. Shevtsova, O.P. Petishko
GASTROENTEROLOGY.2023; 57(3): 135.     CrossRef
Life-long consumption of high level of fruits and vegetables reduces tumor incidence and extends median lifespan in mice
Weimin Guo, Edwin F. Ortega, Dayong Wu, Lijun Li, Roderick T. Bronson, Sarah K. Boehm, Simin Nikbin Meydani
Frontiers in Nutrition.2023;[Epub]     CrossRef